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A B S T R A C T   
Dietary anthocyanins may slow cognitive decline, improve cognitive performance and exert neuroprotective 
effects against neurodegenerative disorders. However, the underlying mechanisms of their action are not fully 
understood. This study investigated the effects of 12-week anthocyanin-rich bilberry extract supplementation 
(0.02%) on global gene expression in the hippocampus of ApoE-/- mice to help the understanding of molecular 
mechanisms underlying anthocyanin neuroprotective effects. Gene expression analysis identified 1698 differ-
ently expressed genes, with 611 downregulated and 1087 upregulated genes. Bioinformatics revealed that these 
genes regulate different biological processes, including neurogenesis, inflammation, metabolism, cell to cell 
adhesion, cytoskeleton organization, and Alzheimer’s and Parkinson’s disease pathology. The bioinformatic 
analysis also proposed potential miRNAs and transcription factors that could be involved in the mediation of 
these nutrigenomic effects. Results from molecular docking also suggested that anthocyanins could bind to top 
transcription factors with, as potential consequence, an impact on their gene expression regulation. Taken 
together, integrated analysis revealed a multi-target mode of action of anthocyanin-rich bilberry extract in the 
hippocampus underlying their neuroprotective properties.   
1. Introduction 
Polyphenols are the largest group of phytochemicals widely found in 
plant foods such as fruits, vegetables, and plant-derived beverages. Over 
the past two decades, these compounds received much attention due to 
the diverse health-promoting effects associated with the consumption of 
polyphenol-rich foods. Indeed, various epidemiological, clinical, and 
preclinical studies support the role of polyphenols in the prevention and 
amelioration of different chronic diseases such as cardiovascular dis-
eases (Kim & Je, 2017; Luís, Domingues, & Pereira, 2018; Menezes et al., 
2017; Rodriguez-Mateos et al., 2019), type-2 diabetes (Cao et al., 2019), 
and neurodegenerative disorders (Lefèvre-Arbogast et al., 2018; Socci, 
Tempesta, Desideri, De Gennaro, & Ferrara, 2017). However, the exact 
molecular mechanisms underlying their health effects remain unclear. 
One of the most studied polyphenols are anthocyanins, plant 
pigments present in berries and berry-derived products that exert a va-
riety of biological activities, including different beneficial effects on 
brain function. In recent years, the effects of anthocyanin-rich foods or 
anthocyanins on cognition have been a focus of a growing number of 
studies. Data from epidemiological studies have shown that higher in-
takes of anthocyanin-rich berries are strongly associated with a slower 
cognitive decline in aged women and a lower probability of moderate 
and poor late-life cognitive function in men (Devore, Kang, Breteler, & 
Grodstein, 2012; Yuan et al., 2019). In a pooled analysis of two US 
cohort studies which examined almost 150 000 people, lower Parkin-
son’s disease (PD) risk was associated with the highest quintile of 
anthocyanin intake (Gao, Cassidy, Schwarzschild, Rimm, & Ascherio, 
2012). Clinical trials suggest that both acute and long-term consumption 
of anthocyanin-rich berries could improve some aspects of cognitive 
function across different age groups (Bensalem et al., 2019; Hein, 
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Whyte, Wood, Rodriguez-Mateos, & Williams, 2019; Travica et al., 
2019). Furthermore, favorable changes in cognitive performance (e.g., 
spatial and short-term memory) have been reported in animal models 
following dietary supplementations with anthocyanin-rich berry ex-
tracts or pure anthocyanins (Khan M.S. et al., 2019; Rendeiro et al., 
2013; Lee, Choi, Lee, Shin, & Cho, 2020). For example, supplementation 
with black rice extract rich in anthocyanins may prevent memory and 
cognition deficits in mice (Lee et al., 2020). In one study, pure antho-
cyanins significantly improved spatial working memory, to an extent 
similar to anthocyanin-rich blueberry powder (Rendeiro et al., 2013). 
Moreover, anthocyanin extract was observed to improve learning and 
memory in mice after surgery and significantly reduced neuro-
inflammation and microglia activation (Zhang et al., 2020). In addition 
to memory and cognition benefits, sufficient evidence has shown neu-
roprotective effects of anthocyanins against neurodegenerative disor-
ders, including Alzheimer’s (AD) and PD (Winter & Bickford, 2019; 
Zhang et al., 2019; Li et al., 2020). 
Notwithstanding the effect on brain function, underlying mecha-
nisms of action of dietary anthocyanins are not fully understood. Some 
of the proposed mechanisms include their passage across the blood–-
brain barrier and modulation of cell signaling pathways and expression 
of genes involved in neuroinflammation, synaptic plasticity, and neu-
rogenesis, especially in the hippocampus, an area of the brain critical for 
learning and memory (Hein et al., 2019; Rees, Dodd, & Spencer, 2018). 
The capacity of anthocyanins to modify cell signaling pathways and 
expression of a large number of different genes involved in the regula-
tion of various processes like inflammatory responses, redox balance, 
cell migration, and metabolism has been previously shown, particularly 
in the vasculature (Krga et al., 2018; Mauray et al., 2012; Rodriguez- 
Mateos et al., 2019). Several studies have also suggested that anthocy-
anins could modulate the expression of microRNAs that are post- 
transcriptional regulators of gene expression (Krga & Milenkovic, 
2019; Krga et al., 2018; Milenkovic et al., 2012; Rodriguez-Mateos et al., 
2019). Despite the proposed pleiotropic nature of anthocyanins, studies 
employing holistic approaches that allow examination of the effect on 
several thousands of targets in the brain are still limited. However, this 
research would be of relevance to generate a first global picture of the 
complex mechanisms that could underlie the effects of these bioactives 
on cognitive function and neurodegenerative diseases. 
Apolipoprotein E deficient (ApoE -/-) mice have been widely used to 
study vascular biology and the effects of nutrition, including poly-
phenols, on the prevention of vascular dysfunction and associated dis-
eases. These mice are characterized by poor lipoprotein clearance, 
accumulation of cholesterol-rich particles in the blood, increased sys-
temic inflammation, and impaired endothelial function, all promoting 
the formation of atherosclerotic plaques (Lo Sasso et al., 2016). 
Numerous studies have shown that dietary supplementation with 
various polyphenols, including anthocyanins, is highly efficient in 
decreasing inflammation, improving endothelial function, and reducing 
the formation of atherosclerotic plaques in the aorta of these mice (Krga 
& Milenkovic, 2019; Mauray et al., 2012, 2009). In addition to causing 
disturbances in the periphery, ApoE deficiency also affects proper brain 
function. Brain-derived ApoE-containing lipoproteins are necessary for 
synapse development, and their depletion leads to synaptic loss and 
dysfunction (Lane-Donovan et al., 2016). Moreover, hypercholester-
olemia and vascular dysfunction lead to reduced cerebral blood flow and 
dysregulated cerebrovasculature (Ayata et al., 2013; Lane-Donovan 
et al., 2016). ApoE-/- mice also exhibit increased blood–brain barrier 
permeability that allows the entry of different neurotoxic substances, 
including inflammatory cytokines, and promotes neuroinflammation 
(Bell et al., 2012; Lane-Donovan et al., 2016). All these effects have been 
associated with synaptic loss, reduced neurogenesis, and cognitive def-
icits (Ayata et al., 2013; Lane-Donovan et al., 2016; Zerbi et al., 2014); 
thus, ApoE-/- mice can also be particularly suitable for examining the 
impact of polyphenols on brain function. 
Taken together, this study aimed to investigate the effects of 
anthocyanin-rich bilberry extract (BE) supplementation on the global 
gene expression in the hippocampus of ApoE-/- mice to help the under-
standing of molecular mechanisms related to the reported neuro-
protective effects of anthocyanin-rich food consumption. 
2. Materials and methods 
2.1. Bilberry extract 
Bilberry (Vaccinium myrtillus L.) anthocyanin-rich extract, Antho 
50®, was provided by Ferlux S.A. (Cournon d’Auvergne, France). It 
contained 52% (w/w) of anthocyanins expressed as cyanidin-3- 
glucoside equivalent as previously determined (Mauray et al., 2009). 
Anthocyanins identified in the extract by HPLC analysis included: 
delphinidin-3-galactoside (11.69%), delphinidin-3-glucoside (13.98%), 
cyanidin-3-galactoside (8.85%), delphinidin-3-arabinoside (9.68%), 
cyanidin-3-glucoside (11.64%), petunidin-3-galactoside (4.18%), 
cyanidin-3-arabinoside (6.47%), petunidin-3-glucoside (9.10%), 
peonidin-3-galactoside (0.75%), petunidin-3-arabinoside (2.62%), peo-
nidin-3-glucoside + malvidin-3-galactoside (9.22%), peonidin-3-arabi-
noside + malvidin-3-glucoside (10.23%) and malvidin-3-arabinoside 
(1.60%) (Supplemental figure S1). The total polyphenol content was 
62 g gallic acid equivalent/100 g of BE, as determined by the Folin- 
Ciocalteu assay (Mauray et al., 2009). 
2.2. Animals and diets 
Pairs of homozygous ApoE-/- mice were obtained from Jackson 
Laboratories (Charles River Laboratories, L’Arbresle, France) and 
interbred to yield the males used in this study. Mice were individually 
housed in wire-bottomed cages at controlled room temperature (22 ±
0.8 ◦C) and relative humidity (55 ± 10%), under a 12 h light/dark cycle. 
The animals had free access to food (control or supplemented with the 
extract) and water. Animals were handled according to the recommen-
dations of the Institutional Ethics Committee of INRA in agreement with 
decree N◦ 87–848. Before the beginning of the experiment, animals were 
fed a standard breeding diet A03 (Safe, Epinay-sur-Orge, France). At the 
age of 8 weeks, mice were randomly divided into two groups of 6 ani-
mals and fed for 12 weeks, either a control diet or a control diet sup-
plemented with 0.02% anthocyanin-rich BE. A detailed composition of 
diets is given in Table S1. During the preparation of the diet mixture, the 
extract was added, and the pellets were prepared. The pellets were 
prepared every 2 weeks to prevent a decrease in anthocyanins with time 
(pellets were kept in vacuum bags, in the dark at 4 ◦C). At the end of the 
experimental period, mice were anesthetized with sodium pentobarbital 
at 40 mg/kg of body weight. Hippocampi were collected, immediately 
frozen in liquid nitrogen, and stored at − 80 ◦C until analyzed. 
2.3. Microarray analysis 
RNA extraction and fluorescent labeling: Hippocampi stored at 
− 80 ◦C were homogenized in lysis buffer for total RNA extraction using 
the SV Total RNA Isolation System (Promega, Madison, WI, USA) as 
recommended by the manufacturer. Total RNA was extracted from eight 
hippocampi: four from mice on a control diet and four from mice on a 
BE-supplemented diet. The quality and integrity of total RNA were 
checked by 1% agarose gel electrophoresis. The cDNAs were reverse- 
transcribed from 5 µg of total RNA with 1 µL of oligo(dT) and 1 µL of 
random primer and labeled with CyTM3- or CyTM5-dCTP using the 
ChipShotTM Direct Labeling System (Promega). The synthesized, labeled 
cDNA was subsequently purified using the ChipShotTM Membrane 
Clean-Up System (Promega). The labeling efficiency and the quantity of 
cDNA were assessed by measuring the absorbance at 260, 550, and 650 
nm with the ND-1000 spectrophotometer (Nanodrop, Wilmington, DE, 
USA). 
Hybridization: Samples of cDNA were hybridized to mouse Operon 
D. Milenkovic et al.                                                                                                                                                                                                                             
Journal of Functional Foods 85 (2021) 104609
3
microarrays (OpArraysTM, Operon Technologies, Alameda, CA, USA). 
Mouse Genome Array-Ready Oligo Set version 4.0 contains 35,852 
longmer probes representing around 25,000 genes and 38,000 gene 
transcripts. Eight microarrays were used for a total of four independent 
comparisons. Hybridization was performed for eight hours at 42 ◦C in 
the Ventana hybridization system (Ventana Medical Systems, S.A, Ill-
kirch, France). Slides were washed twice in 2X saline sodium citrate and 
0.1X saline sodium citrate at room temperature and scanned with the 
Agilent G2505 microarray scanner system (Agilent Technologies, Inc., 
Santa Clara, CA, USA) at 5 µm resolution. 
Image and data analysis: These steps were performed as previously 
detailed (Auclair et al., 2009). Briefly, the ImaGene 6.0 software (Bio-
Discovery, Inc, Proteigene, Saint-Marcel, France) was used to acquire 
the signal and background intensity values for each spot in both chan-
nels. Data were log base-2 transformed and corrected for systemic dye 
bias with the Lowess normalization using GeneSight 4.1 software (Bio-
Discovery, Inc, Proteigene). The log-ratio between BE-supplemented 
and control samples was analyzed with Student’s t-tests using the free 
R 2.1 software (http://www.r-project.org), and Bonferroni correction 
was performed to remove false positives. Genes identified by these 
criteria were considered as differentially expressed between two nutri-
tional conditions. 
2.4. Bioinformatics analyses 
Nutrigenomic data were analyzed with different bioinformatics 
tools. Gene expression profiles in two studied nutritional groups were 
compared by partial least squares-discriminant analysis (PLS-DA) using 
the MetaboAnalyst web-based software (https://www.metaboanalyst. 
ca/) (Chong, Wishart, & Xia, 2019). Ensembl database (http://www. 
ensembl.org/index.html) was used for the identification of official 
symbols and names of differentially expressed genes. To identify bio-
logical processes associated with the identified differentially expressed 
genes, Gene Ontology (GO) analysis was performed using the DAVID 
database, version 6.8 (https://david.ncifcrf.gov/) (Huang, Sherman, & 
Lempicki, 2009), and the obtained results visualized as a TreeMap chart 
by REVIGO platform (http://revigo.irb.hr/) (Supek, Bošnjak, Škunca, & 
Šmuc, 2011). Process network analysis was performed by employing the 
text mining algorithm of MetaCore software suite (Clarivate Analytics, 
Philadelphia, PA, USA, https://portal.genego.com). Overrepresented 
pathways were identified using GeneTrail2, version 1.6 
(https://genetrail2.bioinf.uni-sb.de/workflow.html) (Stöckel et al., 
2016) that allowed the analysis of transcriptomic data by accessing the 
BioCarta and Kyoto Encyclopedia of Genes and Genomes (KEGG) data-
bases. Enriched pathways were also identified using the MetaCoreTM 
software suite (Clarivate Analytics, Philadelphia, PA, USA; 
https://portal.genego.com) and results were combined with GeneTail2- 
obtained data. Interactions between functional groups of genes were 
analyzed with Cytoscape software (version 3.7.2; https://cytoscape. 
org/), using the ClueGO (Bindea et al., 2009). Comparative Tox-
icogenomics Database (http://ctdbase.org/) that provides information 
on chemical-gene/protein interactions, gene-disease, and chemical- 
disease relationships was used to further examine our differentially 
expressed genes and identify genes in common with disease-related ones 
and those inferred with common drugs used to treat cognition disorders, 
AD and PD. 
Analysis of the protein–protein interactions between the proteins 
encoded by differentially expressed genes, including their neighboring 
proteins, was performed by STRING database, version 11.0 
(https://string-db.org/) (Szklarczyk et al., 2019), under the following 
settings: network edges – confidence; active interaction sources – text- 
mining, experiments, databases, and co-expression; minimum required 
interaction score – high confidence (0.700); the maximal number of 
displayed interactions – 1st shell: query proteins only and 2nd shell: no 
more than 5 interactions. The obtained protein network was organized 
in three clusters of functionally connected proteins by kmeans 
clustering, and the overrepresented pathways within the clusters were 
identified by KEGG. OmicsNet (https://www.omicsnet.ca/) (Zhou & 
Xia, 2019) was used to identify transcription factors and miRNA- 
networks potentially involved in regulating the observed nutrigenomic 
effect. Potential binding between top transcription factors identified 
using OmicsNet and some of the most abundant anthocyanins in the 
studied BE, was examined by molecular docking. The 3D structures of 
proteins were retrieved from the Protein Data Bank (www.rcsb.org) and 
structures of anthocyanins from the PubChem database (https://pubch 
em.ncbi.nlm.nih.gov). Docking calculations were performed using the 
DockingServer (https://www.dockingserver.com/web) and 1click 
docking from Mcule.org (https://mcule.com/apps/1-click-docking/). 
2.5. Statistical analysis 
Prism software, version 8.1.1 (GraphPad, La Jolla, CA, USA) was 
used for statistical analysis. Body weight and food intake data were 
analyzed by t-test to compare the effect of BE-supplemented with the 
control diet. The p ≤ 0.05 was considered significant. 
3. Results 
3.1. The effect of BE supplementation on body weight and food intake 
There were no significant differences in body weight between 
ApoE-/- mice fed the control or BE-supplemented diet during the 12 
weeks. Food intakes did not differ between the two studied groups in the 
last weeks of experimental period (Fig. 1). 
3.2. Nutrigenomic effect of anthocyanin-rich BE extract 
A comparison of gene expression profiles in the hippocampus of 
ApoE-/- mice fed the control or BE-supplemented diet by PLS-DA showed 
a distinct separation between the two nutritional groups (Fig. 2). Gene 
expression analysis demonstrated that anthocyanin-rich BE supple-
mentation induced significant changes in hippocampal gene expression. 
There were 2466 probes identified as differentially expressed between 
the two nutritional groups that corresponded to 1698 different genes. Of 
these, 611 genes were identified as down-regulated by BE supplemen-
tation and 1087 as upregulated. The fold-change values varied from 
− 1.98 to 1.95 (Table S2) with an average fold-change of − 1.16 for the 
downregulated genes and 1.22 for the upregulated genes. 
3.3. Bioinformatic analyses of the nutrigenomic effect of anthocyanin-rich 
BE extract 
The nutrigenomic data were further analyzed with different bioin-
formatics tools to define the biological functions of the identified 
differentially expressed genes. A global GO analysis was firstly con-
ducted to determine biological processes associated with these genes. 
This analysis revealed that anthocyanin-rich BE supplementation 
modulated the expression of genes involved in regulating various bio-
logical processes such as brain development, protein phosphorylation, 
cell to cell adhesion, response to hypoxia, and apoptosis (Supplemental 
Fig. 2). Gene network analysis, obtained by the text mining approach, 
was further performed for a more in-depth examination and interpre-
tation of biological functions associated with differentially expressed 
genes. These results suggested that anthocyanin-rich BE altered the 
expression of genes regulating development, cell signaling, inflamma-
tion, cytoskeleton organization, cell cycle, and muscle contraction 
(Fig. 3). More specifically, the development network cluster included 
pathways associated with neurogenesis like axonal guidance, regulation 
of telomerase length, and Hedgehog signaling. Within the cell signaling 
network were pathways like CREM signaling, androgen receptor, pro-
gesterone, and estrogen receptor-1 signaling pathways. The inflamma-
tion network cluster contained genes involved in the regulation of 
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leukocyte chemotaxis and macrophage migration inhibitory factor 
(MIF) signaling, while genes of the cell cycle network cluster were linked 
with the regulation of S phase, G2-M phase, and mitosis. Further analysis 
of transcriptomic data by KEGG, BioCarta databases, and MetaCore, 
revealed cellular pathways associated with the genes which expression 
was significantly modulated by BE supplementation. The over-
represented pathways were related to cell signaling, inflammation and 
cell motility, neuro-related processes, metabolism, cell growth and 
death (Fig. 4A). The most significant cell signaling pathways included 
PI3K-Akt signaling pathway represented with 33 genes (e.g., ITGB7, 
IGF1, GH, PIK3R5, PHLPP2, CREB3L1), Jak-STAT signaling pathway 
with 12 (e.g., IL4, IL13RA1, IFNGR2, IL2, IL23R), HIF-1 signaling 
pathway with 11 (e.g., IGF1R, IFNGR2, FLT1, NOX1, EIF4E) and TNF 
signaling pathway with 9 genes (e.g., TAB2, CCL20, VCAM1, NOD2, 
TRAF3). Among neuro-related pathways, the highest number of genes 
modulated by anthocyanin-rich bilberry extract were identified in Par-
kinson’s disease (e.g., PARK7, NDUFB9, NDUFV2, DRD1, DRD2, GNAI2), 
constitutive and regulated NMDA receptor trafficking (e.g., GRIN2A, 
GRIN2D, DRD1, PPP1CA, PRKAR2A, ADCY1), regulation of AKT(PKB)/ 
GSK3 beta cascade in bipolar disorder (e.g., NTRK1, TNTRK2, NRG1, 
RET, IGF1R), nicotine signaling in dopaminergic neurons (e.g., ADRB1, 
ADRB3, GNAI2, ADCY1) and CREB signaling pathways (e.g., PDYN, 
CAMK4, PPP1CA, PRKAR2A, ADCY1). Overrepresented pathways 
related to inflammation and cell motility included cytokine-cytokine 
receptor interaction (represented with genes like IL4, IL2, CCL20, 
CXCL13, IL13RA1, IFNGR2, TNFRSF9, CX3CR1, FLT1), sublytic effects of 
membrane attack complex (e.g., TRAF6, MCU, EIF2AK3, PLA2G4A, 
HSP90B1, HSP27), platelet-activating factor/PTAFR pathway signaling 
(e.g., LSP1, NFKB2, PLCB2, NFATC1), Th1 and Th2 cell differentiation 
(PLAT, DRD1, PPP1CA, PRKAR2A, PLCB4) as well as cytoskeleton 
Fig. 1. Body weight changes (A) and food intake (B) in ApoE-/- mice with or without dietary supplementation with anthocyanin-rich BE for 12 weeks.  
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remodeling-role of PKA in cytoskeleton reorganization (e.g., MLCK, 
LASP1, PP1CA, ADCY1). Additionally, numerous genes were associated 
with the regulation of metabolism as in purine metabolism (e.g., ADA, 
NME2, PNP, NUDT2, POLR3G), pyrimidine metabolism (e.g., AK3, PNP, 
NUDT2, POLR2C), and oxidative phosphorylation pathways (e.g., 
NDUFA11, NDUFS3, ATP5C1, ATP5J2, COX10). As presented in Fig. 4B, 
these pathways are interconnected among them. 
3.4. Genes associated with neurodegeneration and treatment drugs 
The list of differentially expressed genes was analyzed in the 
Comparative Toxicogenomics Database to identify genes concomitant 
with different neurological disorders, including cognitive dysfunction, 
cognitive disorders, AD and PD. This analysis showed that a high 
number of genes identified as modulated by anthocyanin-rich extract are 
associated with these disorders. Over 1000 genes have overlap with 
Fig. 2. PLS-DA separation of gene expression profiles in the hippocampus of ApoE-/- mice fed control or anthocyanin-rich BE-supplemented diet.  
Fig. 3. The most significant process networks of differentially expressed in the hippocampus of ApoE-/- mice in response to anthocyanin-rich BE supplementation.  
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inferred genes associated with both AD and PD (Fig. 5A). Among the 
common genes are IL4, CD33, TREM2, INPP5, BIN1, ADRB1 and MYH8. 
Regarding cognitive function, over 900 genes are similar to inferred 
genes associated with cognitive disorders and cognitive dysfunction, like 
ACADL, ACTR6, BMP2, CDC40, GDF11, IL4, and NOL10 (Fig. 5B). This 
analysis suggests that genes identified as modulated by anthocyanin-rich 
extract could be involved in the occurrence and development of these 
neurological-related dysfunctions and diseases. Furthermore, we 
analyzed the intersecting genes between our differentially expressed 
genes and genes inferred with common drugs for treating AD, PD, and 
cognitive dysfunctions, including donepezil, galantamine, rivastigmine, 
memantine, levodopa, carbidopa, safinamide, ropinirole, pramipexole, 
benztropine, trihexyphenidyl, rasagiline, and selegiline. Among these 
drugs, we observed an overlap of genes between our differentially 
expressed genes and levodopa (AGT, ATXN2, CYP1A1, DRD1, DRD2, 
GABRG2, GAP43, NSF, PARK7, PDYN, SLC11A2, and STMN1), while 
little overlap was observed for donepezil, ropinirole, and pramipexole. 
3.5. Protein-protein interaction prediction 
Differentially expressed genes were further analyzed to create a 
network of protein–protein interactions and identify central nodes pre-
senting the highest number of functional connections, whose modula-
tion may significantly impact protein–protein interactome and cellular 
function. The obtained network included 1702 nodes (proteins) and 
2992 edges (predicted functional associations). Within the network 
(Fig. 6A), proteins were organized in three distinctive clusters that 
corresponded to proteins mainly involved in ubiquitin-mediated prote-
olysis (green), PI3K-Akt signaling (red), and neuroactive ligand-receptor 
interactions (blue). Proteins that showed the highest degree of 
Fig. 4. Pathways enriched with differentially expressed genes in the hippocampus of ApoE-/- mice in response to anthocyanin-rich BE supplementation. Results 
obtained using BioCarta (#), KEGG (*) database and MetaCore (†) presented as a histogram (A) and network (B). 
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interconnectivity included CUL2, KEAP1, POLR2C, and GNB4 (Fig. 6B). 
3.6. Identification of transcription factors and microRNAs involved in the 
observed nutrigenomic modification 
Finally, to identify potential transcriptional and post-transcriptional 
(microRNAs) regulators that could mediate the observed nutrigenomic 
effect of anthocyanin-rich BE supplementation, the differently expressed 
genes were analyzed by the OmicNet platform. Among the most signif-
icant putative transcriptional regulators were SP1, NFKB1, TRP53, JUN, 
and RELA, while the most significant potentially involved miRNAs 
included mir-124-3p, mir-340-5p, mir-181a-5p, mir-329-3p, mir-15a- 
5p, and mir-9-5p (Fig. 7). Multi-layered 3D examination of regulatory 
networks showed a high level of interconnectivity between regulatory 
elements (either transcription factor or miRNA) and differentially 
expressed genes (Fig. 7). 
3.7. Interaction between major anthocyanins and transcription factors 
Following identification of the potential transcription factors, we 
searched for possible interactions between BE anthocyanin, delphinidin- 
3-galactoside present in the circulation, and proteins of interest: JUN, 
RELA, SP1, p53 (Fig. 8). This anthocyanin presented potential strong 
interactions with proteins of interest, with the binding affinity varying 
between − 7.2 and − 8.52 kcal/mol. We observed binding energy of 
− 7.2 kcal/mol for interaction between delphinidin-3-galactoside and 
JUN, − 8.16 kcal/mol for interaction with RELA, − 8.52 for SP1, and 
binding energy of − 7.25 kcal/mol for p53. Moreover, in-silico docking 
analysis also showed that cyanidin-3-glucoside can interact with CREBP 
transcription factor (-8.1 kcal/mol) or RELA (-7.1 kcal/mol) (Supple-
mental Fig. 3). Therefore, these results suggest that anthocyanins pre-
sent in the extract can interact with proteins involved in gene expression 
regulation, presenting a possible mode of action of anthocyanins. 
4. Discussion 
In this study we showed that 12-week dietary supplementation with 
anthocyanin-rich BE changed the global gene expression profile in the 
hippocampus of ApoE-/- mice. Bioinformatic analyses suggested that the 
identified 1698 differentially expressed genes could be involved in 
various cellular and molecular processes, including inflammation, 
neuronal function, metabolic processes and signal transduction, that are 
involved in cognitive function and neurodegenerative disorders like AD 
and PD. Furthermore, some transcription factors and miRNAs are sug-
gested as potential mediators in the observed nutrigenomic effect. 
The dose used in this study can be nutritionally achievable in humans 
and can exert vasculo-protective effects. We have previously shown that 
the same extract exerts an antiatherogenic effect in ApoE-/- mice after 
dietary supplementation at 0.02% in the diet (Mauray et al., 2009) and 
can also modulate the expression of genes associated with atheroscle-
rotic effects in the aorta, as observed using microarray analysis (Mauray 
et al., 2012). The supplementation of the diet with 0.02% of this extract 
(i.e., around 0.01% of anthocyanin glycosides) may correspond to an 
equivalent human intake of about 30 mg of anthocyanidins per day 
Fig. 4. (continued). 
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when expressed on the basis of diet content (for a human food intake 
estimate of 500 g of dry weight). We have previously reported that the 
estimated mean intakes of anthocyanins in Europe range from 19.8 to 
64.9 mg/day for men and from 18.4 to 44.1 mg/day for women, while in 
the United States, the reported mean consumption is 12.6 mg/day for 
women and 10.5 mg/day for men (Krga & Milenkovic, 2019). Therefore, 
the dose used in this study is nutritionally relevant and has been shown 
to exert vasculo-protective effects and genomic modification in the 
aorta. 
The notion of neuroinflammation includes the response of immune 
brain cells toward infections but also infiltration of the brain by cells of 
the innate and adaptive immune systems. An inflammatory response, 
particularly chronic neuroinflammation, is considered detrimental and 
damaging to nervous tissue in the central nervous system (CNS) by 
increased levels of cytokines, proteases, glutamate, free radicals, and 
activation of glial cells (de Araújo Boleti et al., 2020). This inflammatory 
process within the brain is one of the key factors triggering different 
neurological diseases, such as AD, PD, stroke, and cognitive dysfunction 
(de Araújo Boleti et al., 2020; Zhao et al., 2019). Under inflammatory 
conditions, activated microglial cells can increase levels of proin-
flammatory cytokines (e.g., tumor necrosis factor-α, interleukin-1β) and 
nitric oxide, which are considered hallmarks of neurodegenerative dis-
eases, and in turn induce neuronal death. Neurodegenerative diseases 
are chronic, progressive, and incapacitating disorders that affect pa-
tients’ quality of life and frequently result in death. Most of them have 
no therapy, and the existing treatments aim to ease the symptoms and 
delay their progression (de Araújo Boleti et al., 2020). In our study, we 
observed that anthocyanin-rich BE modulated a certain number of genes 
involved in the regulation of inflammation, which expression profile is 
suggestive of an anti-inflammatory effect. This observation suggests that 
these bioactives could lower inflammation and consequently prevent or 
delay the onset of neurodegenerative diseases and cognitive disorders. 
Moreover, interrogation of genes associated with AD, PD and cognitive 
dysfunction and comparison with our differentially expressed genes 
have revealed high similarity among them. Our hypothesis is in agree-
ment with few studies that revealed the capacity of anthocyanin-rich 
foods to improve cognitive function and delay AD and PD onset. In a 
recent randomized, double-blind placebo-controlled parallel study with 
middle-aged, overweight adults, anthocyanin-rich Aronia melanocarpa 
extract consumption for 24 weeks showed beneficial effects on cognitive 
performance and blood pressure in individuals at risk of cognitive 
decline (Ahles et al., 2020). In a mice model of AD, it has been observed 
that supplementation of a diet with an anthocyanin-rich extract from 
Hibiscus sabdariffa could prevent AD by exerting anti-inflammatory, 
anti-acetylcholinesterase, antioxidant, and anti-amyloidogenic activ-
ities (El-Shiekh, Ashour, Abd El-Haleim, Ahmed, & Abdel-Sattar, 2020). 
In addition, there are also data, though limited, suggesting that antho-
cyanins and other polyphenols could similarly contribute to prevent or 
delay PD (Haider, Madiha, & Batool, 2020; Jung & Kim, 2018). 
In this study we showed that supplementing mice diet with a nutri-
tionally relevant dose of anthocyanin-rich extract could significantly 
change the global gene expression profile. Therefore, this observation 
supports the capacity of anthocyanins and other bioactives present in 
the extract to exert in vivo a significant genomic effect in the brain. 
Interestingly, this finding nicely completes and extends the very few 
studies previously reporting that these bioactives can modulate gene 
expression in vivo in the brain. For example, bilberry anthocyanins were 
reported to modulate the expression of inflammatory factors (TNF-α, NF- 
κβ, IL-1β, IL-6, iNOS, COX-2, and CD33), chemokine receptor CX3CR1, 
microglia homeostatic factors (TREM2 and TYROBP) and Toll-like re-
ceptors (TLR2 and TLR4) (Li et al., 2020). Supplementation with purple 
sweet potato naturally occurring anthocyanins can promote hippocam-
pal brain-derived neurotrophic factor expression by activation of AMP- 
activated protein kinase (Zhuang et al., 2019) and decrease the 
expression of TNF-α, IL-1β, suppressor of cytokine signaling 3, allograft 
inflammatory factor 1 and galectin-3 (Qin et al., 2019). Of note, these 
rare studies used the targeted approach, which encompasses the analysis 
of the expression of a few specific genes. It has been shown that 
anthocyanin in vivo can modulate a large number of genes, over a few 
hundred (Mauray et al., 2010, 2012; Rodriguez-Mateos et al., 2019). 
Therefore, the use of an untargeted approach, as performed in this study, 
can enable identifying all the genes whose expression can be modulated 
by anthocyanins and appears as the most adapted method to determine, 
as precisely as possible, the molecular mechanisms underlying their 
health properties. 
Bioinformatic analysis of identified differentially expressed genes 
suggests that anthocyanin-rich BE could modulate the expression of 
genes involved in regulating different cellular functions. A group of gene 
networks and cellular pathways involved in the control of inflammation 
has been revealed. Among the genes and pathways identified is a group 
of genes involved in chemotaxis. For example, we observed a decrease in 
the expression of a gene coding for chemokine (C-C motif) ligand 20 
(CCL20). Increased brain CCL20 was detected in response to neuron- 
derived extracellular α-synuclein stress and contributed to neuro-
inflammation in neurodegenerative diseases (Lee, Kim, & Lee, 2010). 
Accordingly, targeting CCL20 using antibodies was shown to reduce 
inflammation in mice (Liao, Zhang, Gu, & Sun, 2020). We also observed 
a decrease in the expression of genes encoding CXC chemokine ligand 13 
(CXCL13) and CX3C chemokine receptor 1 (CX3CR1). The CXCL13 has 
been implicated in the recruitment of B cells to the CNS in different 
neuroinflammatory diseases, but also neurodegeneration and cognitive 
impairment (Shen et al., 2020). Reduced expression of chemokine re-
ceptor CX3CR1 by small interfering RNA was shown to decrease levels of 
Fig. 5. Venn diagrams showing the overlap between the identified differen-
tially expressed genes and genes implicated in Alzheimer’s and Parkinson’s 
diseases (A) or cognition disorders and cognitive dysfunction (B). 
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proinflammatory cytokines, such as TNF-α, IL-1β, and IL-6 in a mouse 
brain after ischemia (Liu et al., 2015). Moreover, reduced hippocampal 
CX3CR1 levels, downregulation of several proinflammatory cytokines, 
and reversed cognitive dysfunction were observed in an AD animal 
model after administration of bilberry anthocyanins (Li et al., 2020). 
Here, we also detected an increased expression of IL4 that codes for an 
anti-inflammatory cytokine produced by Th2 cells, whose capacity to 
attenuate age- and AD-associated neuroinflammation was reported in 
several animal studies (Boccardi et al., 2019; Maher, Nolan, & Lynch, 
2005). Therefore, the modulation of expression of these and other che-
mokines and their receptors in the hippocampus following 
supplementation with anthocyanin-rich BE suggests its anti- 
neuroinflammatory action and protective effect against neurodegener-
ative disorders. 
Our bioinformatic analysis also suggests that BE could modulate the 
expression of several genes involved in different metabolism-related 
pathways such as oxidative phosphorylation (OXPHOS), purine, and 
pyrimidine metabolism. The OXPHOS is a metabolic pathway respon-
sible for the majority of ATP production in the brain that powers cell 
signaling and neuronal activity processes (Bergman & Ben-Shachar, 
2016). Altered expression of several components of the OXPHOS sys-
tem, such as subunits of mitochondrial complex 1 and ATP synthases, 
Fig. 6. Interactions between proteins encoded by genes modulated by anthocyanin-rich BE-supplementation (A), with top proteins forming the highest number of 
interactions (B). Proteins are grouped in clusters, green denotes protein mainly involved in ubiquitin-mediated proteolysis, red in PI3K-Akt signaling and blue in 
neuroactive ligand-receptor interactions. 
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have been described in the AD brain and may be associated with 
disturbed energy production and neuronal dysfunctions observed in this 
condition (Adav, Park, & Sze, 2019; Canchi et al., 2019). Nucleotides 
also participate in energy metabolism as well as regulation of neuronal 
activity, blood–brain barrier permeability and cognitive function. 
Additionally, deregulated expression of several genes involved in their 
metabolism have been described in the brain of AD and PD subjects 
(Ansoleaga et al., 2015; Garcia-Esparcia, Hernández-Ortega, Ansoleaga, 
Carmona, & Ferrer, 2015). Thus, these data suggest that by modulating 
the expression of genes related to these metabolic pathways, 
anthocyanin-rich BE consumption might affect cellular metabolism and 
exert neuroprotective effects. 
Among the identified differentially expressed genes were also those 
implicated in PI3K-Akt signaling that manages various complex events 
involved in regulating microglia neuroinflammatory responses, meta-
bolism, and neuronal survival (Cianciulli et al., 2020). PI3K-Akt dysre-
gulation has been observed in different neurodegenerative diseases, 
including AD, PD and Huntington’s diseases, and recent evidence sug-
gests the preventive and therapeutic potential of the modulation of this 
signaling in these pathologies (Cianciulli et al., 2020; Rai et al., 2019). 
PI3K-Akt was also identified as a notable pathway in our protein–protein 
interaction analysis. This analysis also revealed several genes encoding 
different enzymes involved in ubiquitin-mediated proteolysis as poten-
tially important regulatory nodes. The ubiquitin–proteasome system is 
Fig. 7. Top 20 putative transcription factors and miRNA potentially regulating nutrigenomic effect of anthocyanin-rich BE supplementation in the hippocampus of 
ApoE-/- mice with the multi-layered layout of regulatory networks of transcription factors and miRNAs. Green nodes represent transcription factors, light blue nodes- 
miRNAs, red nodes-differentially expressed genes. 
Fig. 8. Docking analysis of major BE anthocyanin, delphinidin-3-galactoside, with the top transcription factors identified in bioinformatics analysis. Each left image 
shows the strongest binding conformation and each right the interaction analyses between the ligand and A) SP1, B: RELA, C: TRP53, D: JUN. 
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essential for the degradation of regulatory and damaged proteins and 
control of synaptic plasticity and memory, while its dysregulation has 
been associated with protein accumulation, aberrant synaptic function, 
and cognitive deficits in different neurodegenerative disorders (Ola-
barria et al., 2019). Among genes encoding ubiquitination-associated 
enzymes is UBE3A (ubiquitin-protein ligase E3A), found upregulated 
by BE. UBE3A expression was reported significantly decreased in the 
hippocampus of cognitively impaired aged rats (Fletcher et al., 2014), 
and its neuronal loss was associated with synaptic dysfunction in an AD 
mouse model (Olabarria et al., 2019). Thus, modulation of the expres-
sion of this and other genes involved in ubiquitin-mediated proteolysis 
by anthocyanin-rich BE suggests its potential impact on synaptic 
function. 
In line with this hypothesis, the bioinformatic analysis has also 
revealed a group of genes involved in cellular pathways of AD and PD 
development. For example, a group of genes coding for glutamate re-
ceptors has been identified. L-Glutamate is the most abundant neuro-
transmitter in the mammalian CNS that mediates excitatory synaptic 
transmission (Zhou & Danbolt, 2014). It interacts with both ionotropic 
and metabotropic receptors, which belong to the group of glutamate 
receptors involved in various processes, from learning and memory to 
neurodegeneration such as AD, PD, and Huntington’s disease (Serwach 
& Gruszczynska-Biegala, 2019). Among glutamate receptor coding 
genes is GRIN3A, for which there is growing evidence of its role in 
various disorders of the CNS, including Huntington’s disease and 
cocaine addiction (Kehoe, Bernardinelli, & Muller, 2013). These re-
ceptors are part of glutamatergic synapses, and in the brain, over 40% of 
neuronal synapses are glutamatergic, with disturbances in glutamatergic 
function identified as implicated in the pathophysiology of AD (Bukke 
et al., 2020). We also identified a group of genes involved in the endo-
cannabinoid signaling pathway. The endocannabinoid system plays an 
essential modulatory role in the endocrine, immune, and brain tissue 
and includes elementarily G protein-coupled receptors, known as 
cannabinoid receptors, and the endogenous agonists of these receptors, 
known as endocannabinoids. The endocannabinoid system constitutes a 
crucial player in developing various neuropathological states, including 
depression, AD, PD, multiple sclerosis, and epilepsy (Charytoniuk et al., 
2020). Together with other pathways identified as involved in the 
regulation of brain function, we can suggest that anthocyanin-rich BE 
modulate the expression of genes involved in cellular pathways regu-
lating neuronal function. The expression profile of these genes is 
consistent with the capacity of the anthocyanin-rich BE to maintain 
neuronal function. 
In this study, we further performed bioinformatics analysis on the 
gene expression data to identify putative transcription factors whose 
activity could be modulated by anthocyanin-rich BE supplementation 
and associated with the observed changes in the hippocampal gene 
expression. Among the identified transcription factors was SP1 that 
regulates the expression of key genes linked with AD pathology and 
contributes to cognitive dysfunction (Subaiea, Adwan, Ahmed, Stevens, 
& Zawia, 2013). Additionally, both NFKB1 and RELA subunits of the NF- 
κB transcription factor were identified. The NF-κB is best known for its 
role in inflammation but is also implicated in synaptic plasticity, 
learning, and memory, and its dysregulation has been reported in 
neurodegenerative diseases (Snow & Albensi, 2016). Anthocyanin-rich 
extracts were previously reported to improve memory and reduce neu-
roinflammation by inhibiting NF-κB activation in the brain of high-fat 
diet-fed (Snow & Albensi, 2016) and LPS-treated mice (Khan M.S. 
et al., 2019). Among the identified transcription regulators were also 
JUN and p53, which modulate hippocampal gene expression during 
long-term potentiation (Mitchnick et al., 2016) and are implicated in 
neuronal loss and cognitive deficits in different neurological disorders 
(Szybińska & Leśniakx, 2017; Tang et al., 2020). Recently, anthocyanins 
from chokeberry were shown to alleviate the age-associated cognitive 
decline and response capacity in senescence-accelerated mice in part by 
reducing brain p53 and p-p53 levels (Wu et al., 2019). Thus, these 
results suggest that dietary supplementation with anthocyanin-rich BE 
could modulate the activity of various transcription factors and conse-
quently alter the expression of genes associated with maintaining 
cognitive function, memory, and prevention of neurodegenerative dis-
eases. In line with this hypothesis, our docking analysis is supportive of 
the capacity of BE anthocyanins to directly bind to these transcription 
factors, this binding could contribute to the observed changes in gene 
expression following anthocyanin-rich extract supplementation. It 
should be noted that in addition to significant levels of anthocyanins, BE 
also contained other polyphenols, including quercetin and phenolic 
acids, which have been previously reported to exert neuroprotective 
effects (Khan H. et al., 2019; Szwajgier, Borowiec, & Pustelniak, 2017). 
Therefore, the potential contribution of other polyphenolic compounds 
to the observed nutrigenomic effect of BE cannot be ruled out. 
Another possible mechanism through which BE could induce the 
observed nutrigenomic effect is the modulation of miRNAs, the small 
non-coding RNAs that regulate the gene expression at the post- 
transcriptional level. The most significant putative miRNA identified 
in our bioinformatics analysis was miR-124-3p. It is involved in 
neuronal differentiation, synaptic plasticity, and regulation of learning 
and memory, with altered expression observed in neurological disorders 
like AD, PD, and cerebral ischemic stroke (Geng, Liu, & Chen, 2017). 
Previously, intracerebroventricular administration of a red wine poly-
phenol resveratrol for one week reduced hippocampal mir-124 levels, 
which was associated with improved long-term potentiation and mem-
ory formation in these mice (Zhao et al., 2013). The identified putative 
miRNAs also included some associated with dendritogenesis (miR-329- 
5p and miR-15a-5p) (Zhang et al., 2014), axon guidance (miR-340-5p) 
(Pietrzykowski & Spijker, 2014), hippocampus-dependent memory 
formation, blood–brain barrier function, and cognition (miR-181a-5p, 
miR-9-5p) (Wei et al., 2017; Wu et al., 2019). Recently, anthocyanin gut 
metabolite, ferulic acid, was shown to reverse spatial memory formation 
and reduce neuronal death in adult rats exposed to neonatal hypoxic- 
ischemic brain damage by inhibiting hippocampal miR-9 expression 
(Yao et al., 2020). To the best of our knowledge, no other studies 
examined the effect of anthocyanins on the brain expression of any of 
the top miRNAs identified in our analysis. However, these compounds 
have been previously reported to modulate miRNAs in other tissues and 
cells (Krga et al., 2018; Ma & Ning, 2019; Milenkovic et al., 2012). 
Therefore, by potentially modulating the expression of the aforemen-
tioned miRNAs, anthocyanin-rich BE could induce the observed nutri-
genomic effects associated with cognitive function and 
neurodegenerative diseases. However, needless to say that further in-
vestigations are needed to confirm the impact of dietary anthocyanins 
on miRNAs as post-transcriptional regulators of different physiological 
and pathophysiological processes in the hippocampus. 
In conclusion, in the present study, we showed that anthocyanin-rich 
bilberry extract supplementation could significantly affect the global 
gene expression in the hippocampus of ApoE-/- mice. The obtained re-
sults allow to make assumption about the potential molecular mecha-
nisms underlying the reported neuroprotective effects of anthocyanin- 
rich food consumption. Bioinformatic analyses suggested that these 
genes are relevant in the regulation of neuroinflammation, neuronal 
function, or brain vascular endothelial function, processes that are 
implicated in cognitive function and neurodegenerative disorders like 
AD and PD (Fig. 9). Moreover, beyond neurodegenerative disorders, the 
results suggest that this type of supplementation could also be beneficial 
in the setting of neuropsychiatric disorders. These results, therefore, 
provide novel findings of the potential molecular targets and mecha-
nisms of neuroprotective action of anthocyanin-rich food sources. Still, 
further mechanistic studies validating these mechanisms in vivo are 
warranted. 
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